儿科急诊出院时生命体征异常患者的结局
这项回顾性队列研究纳入2018年7月至2019年6月两所儿科急诊就诊后出院的0-18岁儿童,分析出院时最后记录生命体征异常与48小时内返诊、再入院及不良结局的关系。97824名儿童中17661名(18.1%)出院时生命体征异常,其中404名(2.28%)返诊,95名(23.5%)在48小时内因同一主诉再入院;生命体征正常者48小时返诊率为2.45%(p=0.219)。2项及以上生命体征异常(OR 1.6;95%CI 1.23-2.07)、年龄小于3岁(OR 1.69,95%CI 1.39-2.06)及初始分诊级别高(OR 1.34;95%CI 1.1-1.63)与返诊 odds 增加相关;初始分诊级别高(OR 2.58;95%CI 1.59-4.2)和年龄小于3岁(OR 2.20,95%CI 1.36-3.55)也与再入院相关。返诊患儿中4名需PICU入住,但无死亡、心肺复苏或气管插管。
要点
- 97824名儿科急诊就诊儿童中17661名(18.1%)出院时生命体征异常,其中404名(2.28%)48小时内返诊,95名(23.5%)因同一主诉再入院。
- 生命体征异常组48小时返诊率为2.28%,生命体征正常组为2.45%,两组差异无统计学显著(p=0.219)。
- 出院时2项及以上生命体征异常(OR 1.6;95%CI 1.23-2.07)、年龄小于3岁(OR 1.69,95%CI 1.39-2.06)或初始分诊级别高(OR 1.34;95%CI 1.1-1.63)的患儿返诊 odds 增加。
- 初始分诊级别高(OR 2.58;95%CI 1.59-4.2)和年龄小于3岁(OR 2.20,95%CI 1.36-3.55)与返诊后再入院相关。
- 返诊患儿中4名需PICU入住,无死亡、心肺复苏或气管插管,严重不良结局少见。
适用人群与场景
- 2018年7月至2019年6月在两所儿科急诊就诊后出院的0-18岁儿童。
- 纳入出院时最后记录生命体征异常的患儿;生命体征被判定为录入错误者排除:心率<30或≥300、呼吸频率为0或≥100、血氧饱和度<50。
- 初诊时已宣告死亡的患儿排除。
诊断标准与关键阈值
- 生命体征异常以出院时最后记录的生命体征判断。
- 录入错误排除阈值:心率<30或≥300、呼吸频率为0或≥100、血氧饱和度<50。
红旗征与不能漏的情况
- 出院时2项及以上生命体征异常、年龄小于3岁或初始分诊级别高的患儿返诊 odds 增加,需关注。
- 返诊患儿中4名需PICU入住,虽无死亡、心肺复苏或气管插管。
研究设计与关键结果
- 回顾性队列研究,纳入两所儿科急诊2018年7月至2019年6月出院的0-18岁儿童,比较出院时生命体征异常与正常者的结局。
- 研究期间急诊共评估97824名儿童,17661名(18.1%)出院时生命体征异常;其中404名(2.28%)返诊,95名(23.5%)在48小时内因同一主诉再入院。
- 生命体征正常者48小时返诊率为2.45%,与异常组2.28%相比差异无统计学显著(p=0.219)。
- 出院时2项及以上生命体征异常(OR 1.6;95%CI 1.23-2.07)、年龄小于3岁(OR 1.69,95%CI 1.39-2.06)、初始分诊级别高(OR 1.34;95%CI 1.1-1.63)与返诊 odds 增加相关。
- 初始分诊级别高(OR 2.58;95%CI 1.59-4.2)和年龄小于3岁(OR 2.20,95%CI 1.36-3.55)与返诊后再入院相关。
- 返诊患儿中4名需PICU入住,无死亡、心肺复苏或气管插管。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 出院时生命体征异常在儿科急诊常见(18.1%),但48小时返诊率与生命体征正常者无显著差异(2.28% vs 2.45%,p=0.219),严重不良结局少见。
- 出院时2项及以上生命体征异常、年龄小于3岁或初始分诊级别高的患儿返诊 odds 增加,年龄小于3岁和初始分诊级别高也与再入院相关,作者认为这些因素可识别需关注的高风险患儿。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Vital signs (VS) are used to triage and identify children at risk for severe illness. Few studies have examined the association of pediatric VS at emergency department (ED) discharge with patient outcomes.
OBJECTIVE: To determine if children discharged from the ED with abnormal VS have high rates of return visits, admission or adverse outcomes.
METHODS: We conducted a retrospective cohort study of children discharged from 2 pediatric EDs with abnormal VS between July 2018-June 2019. We queried electronic health records (EHR) for children ages 0-18 years discharged from the ED with abnormal last recorded VS. VS were considered erroneously entered and thus excluded from analysis if heart rate was <30 or ≥ 300, respiratory rate was 0 or ≥ 100 or oxygen saturation was <50. Patients who were declared deceased at index visit were excluded. Demographic, clinical, and outcome data including return visits within 48 h and adverse outcomes after the initial ED discharge were obtained.
RESULTS: Of the 97,824 children evaluated in the EDs during the study period, 17,661 (18.1%) were discharged with abnormal VS. 404 (2.28%) returned to the ED, of which 95 (23.5%) were admitted for the same chief complaint within 48 h. In comparison, the 48-h return rate for children discharged with normal VS was 2.45% (p = 0.219). Children discharged with abnormal VS were more likely to return if they had 2 or more abnormal VS (OR 1.6; 95% CI 1.23-2.07), were less than 3 years old (OR 1.69, 95% CI 1.39-2.06) or their initial acuity level was high (OR 1.34; 95% CI 1.1-1.63). Higher initial acuity level and age less than 3 years were also associated with admission at revisit (OR 2.58; 95% CI 1.59-4.2; OR 2.20, 95% CI 1.36-3.55). Four of the children who returned required PICU admission, but none died, required CPR or endotracheal intubation.
CONCLUSION: Although many children were discharged from the ED with abnormal VS, few returned and required admission. Having 2 or more abnormal VS, age less than 3 years and higher acuity increased odds of revisit. Few children suffered serious adverse outcomes.
参考来源
- Kazmierczak M, Thompson AD, DePiero AD, et al. Outcomes of patients discharged from the pediatric emergency department with abnormal vital signs. Am J Emerg Med. 2022. PMID: 35526404. doi:10.1016/j.ajem.2022.04.021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。